CA9 and prostate cancer: In prostate cancer, MB immunostaining positively correlated with CAIX (r = 0.246) (20) and in invasive breast cancer MB immunostaining positively correlated with CAIX (r = 0.286) and HIF-2 α (r = 0.293) (18).